Buzzard C J, Pfister S L, Campbell W B
Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas.
Circ Res. 1993 May;72(5):1023-34. doi: 10.1161/01.res.72.5.1023.
This study was designed to characterize the endothelium-dependent contracting factor (EDCF) released by arachidonic acid (AA) and methacholine (MeCH) in the rabbit pulmonary artery. AA and MeCH contract the rabbit pulmonary artery; however, the effects of both are blocked by denuding the vessels and by administration of indomethacin (a cyclooxygenase inhibitor), dazoxiben (a thromboxane [TX] synthase inhibitor), and SQ29548 (a TXA2/prostaglandin [PG] H2 receptor antagonist). When segments of rabbit pulmonary artery were incubated with [14C]AA and the [14C] metabolites were resolved by reverse-phase high-performance liquid chromatography (HPLC), radioactive products were observed that comigrated with 6-keto-PGF1 alpha and TXB2, the stable metabolites of prostacyclin and TXA2. The TXB2 radioactive peak was rechromatographed on normal-phase HPLC and again migrated with TXB2. Finally, the structures of derivatized [14C]6-keto-PGF1 alpha and [14C]TXB2 peaks were confirmed by gas chromatography/mass spectrometry. The synthesis of [14C]6-keto-PGF1 alpha and [14C]TXB2 was inhibited by removal of the endothelium and by indomethacin. Dazoxiben inhibited the synthesis of [14C]TXB2 but not [14C]6-keto-PGF1 alpha. Using specific radioimmunoassays, AA and MeCH stimulated 6-keto-PGF1 alpha and TXB2 release. Indomethacin blocked the production of both 6-keto-PGF1 alpha and TXB2, whereas dazoxiben only blocked TXB2. In a superfusion/bioassay system, AA stimulated an endothelium-intact donor vessel to release a labile substance that contracted an indomethacin-treated endothelium-denuded recipient vessel. The EDCF released by AA had an approximate half-life of 30 seconds. Cultured rabbit pulmonary arterial endothelial cells synthesized 6-keto-PGF1 alpha but not TXB2. Immunohistochemical studies indicated the presence of cyclooxygenase, but not TX synthase, in pulmonary artery endothelial cells. TXA2 appears to be the EDCF released by AA and MeCH in rabbit pulmonary artery; however, TXA2 is not produced by endothelial cells but may arise from cells that adhere to the luminal surfaces, such as platelets or macrophages.
本研究旨在表征花生四烯酸(AA)和乙酰甲胆碱(MeCH)在兔肺动脉中释放的内皮依赖性收缩因子(EDCF)。AA和MeCH可使兔肺动脉收缩;然而,通过剥脱血管内皮以及给予吲哚美辛(一种环氧化酶抑制剂)、达唑昔班(一种血栓素[TX]合酶抑制剂)和SQ29548(一种TXA2/前列腺素[PG]H2受体拮抗剂),二者的作用均被阻断。当兔肺动脉段与[14C]AA一起孵育,且[14C]代谢产物通过反相高效液相色谱(HPLC)分离时,观察到放射性产物与6-酮-PGF1α和TXB2(前列环素和TXA2的稳定代谢产物)共迁移。TXB2放射性峰在正相HPLC上重新色谱分析,再次与TXB2迁移。最后,通过气相色谱/质谱法确认了衍生化的[14C]6-酮-PGF1α和[14C]TXB2峰的结构。去除内皮和给予吲哚美辛可抑制[14C]6-酮-PGF1α和[14C]TXB2的合成。达唑昔班抑制[14C]TXB2的合成,但不抑制[14C]6-酮-PGF1α的合成。使用特异性放射免疫测定法,AA和MeCH刺激6-酮-PGF1α和TXB2的释放。吲哚美辛阻断6-酮-PGF1α和TXB2的生成,而达唑昔班仅阻断TXB2的生成。在灌注/生物测定系统中,AA刺激完整内皮的供体血管释放一种不稳定物质,该物质使经吲哚美辛处理的去内皮受体血管收缩。AA释放的EDCF半衰期约为30秒。培养的兔肺动脉内皮细胞合成6-酮-PGF1α,但不合成TXB2。免疫组织化学研究表明肺动脉内皮细胞中存在环氧化酶,但不存在TX合酶。TXA2似乎是AA和MeCH在兔肺动脉中释放的EDCF;然而,TXA2并非由内皮细胞产生,而是可能源于粘附于管腔表面的细胞,如血小板或巨噬细胞。